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SUMMARY
Hematopoietic stem cells (HSCs) are generated from
specialized endothelial cells of the embryonic aorta.
Inflammatory factors are implicated in regulating
mouse HSC development, but which cells in the
aorta-gonad-mesonephros (AGM) microenvironment
produce these factors is unknown. In the adult, mac-
rophages play both pro- and anti-inflammatory roles.
We sought to examinewhethermacrophages or other
hematopoietic cells found in the embryo prior to HSC
generation were involved in the AGMHSC-generative
microenvironment. CyTOF analysis of CD45+ AGM
cells revealed predominance of two hematopoietic
cell types, mannose-receptor positive macrophages
and mannose-receptor negative myeloid cells. We
show here that macrophage appearance in the AGM
was dependent on the chemokine receptor Cx3cr1.
These macrophages expressed a pro-inflammatory
signature, localized to the aorta, and dynamically
interacted with nascent and emerging intra-aortic he-
matopoietic cells (IAHCs). Importantly, upon macro-
phage depletion, no adult-repopulating HSCs were
detected, thus implicating a role for pro-inflammatory
AGM-associated macrophages in regulating the
development of HSCs.
INTRODUCTION
Hematopoietic stem cell (HSC) transplantation is a curative
regenerative therapy for patients with blood-related disorders.
More than 50,000 transplants are carried out annually world-
wide. For patients without a histo-compatible donor, the lack
of matched HSCs is a serious problem. Given that HSCs do
not expand in in vitro cultures, patient-derived induced pluripo-
tent stem cells (iPSCs) may be an alternative source for the de
novo production of HSCs. Although it is possible to differentiate
iPSCs and to reprogram cells into hematopoietic progenitors,
the generation of robust in vivo repopulating HSCs in vitro has
not yet been achieved without genetic manipulation (Doulatov
et al., 2013). Thus, an understanding of the in vivomicroenviron-
ment in which HSCs are first generated should provide insights
into improving such in vitro strategies.
HSCs arise in the AGM (aorta-gonad-mesonephros) region
(Medvinsky and Dzierzak, 1996) and other major arteries (de
Bruijn et al., 2000) through a transdifferentiation process called
endothelial-to-hematopoietic transition (EHT) (Dzierzak and
Bigas, 2018; Jaffredo et al., 1998). In the mouse embryo, HSCs
are generated in a complex and dynamic microenvironment
during a short period of developmental time (embryonic day [E]
10.5–E12.5) (Zovein et al., 2008). Tissues ventral to the AGM
(Peeters et al., 2009; Taoudi and Medvinsky, 2007), including
cells of the sympathetic nervous system (Fitch et al., 2012), exert
a positive effect on HSC emergence. Moreover, AGM-derived
stromal cell lines produce regulators, such as bone morphoge-
netic protein (BMP) and hedgehog (Hh), that support HSC gener-
ation and/or maintenance, as demonstrated by transcriptional
profiling and culture approaches (Charbord et al., 2014; Crisan
et al., 2015; Durand et al., 2007; Renstro¨m et al., 2009).
Hematopoietic development occurs in at least three distinct
waves (Dzierzak and Bigas, 2018), with HSCs made only in the
last wave. Macrophages are generated in all three waves, first
in the mouse yolk sac (YS) beginning at E7.5 (Palis et al., 1999;
Tober et al., 2007), then in the second YS wave at E8.25 (Gomez
Perdiguero et al., 2015) from erythro-myeloid progenitors (EMPs)
(Frame et al., 2013; Palis et al., 1999), and finally from HSC-
derived monocytes. EMPs emigrate to the embryo body, where
they give rise to hematopoietic cells found in the embryo prior to
HSC emergence at E10.5. Because the three distinct waves of
hematopoietic generation temporally overlap, the hematopoietic
cells generated in the earlier two waves could be part of the
microenvironment that affects the production of HSCs intraem-
bryonically in the third wave (Chen et al., 2011; Espı´n-Palazo´n
et al., 2014; Li et al., 2014; Travnickova et al., 2015).
Macrophages from the first two waves function developmen-
tally in tissue remodeling (Hume et al., 1983; Leid et al., 2016;
Munro et al., 2019). They infiltrate the limbs, mandibular arches,
liver, kidneys, and brain between E9.5 and E10.5 and represent
2%–5% of total cells in these tissues (Rae et al., 2007). In adult
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tissues, macrophages regulate steady-state hematopoiesis
(Gordy et al., 2011), hematopoietic cell egress (Jaiswal et al.,
2009), and erythrocyte maturation (Manwani and Bieker, 2008).
They are best known for their innate immune pro- and anti-
inflammatory functions in response to trauma, tissue damage,
and tissue repair.
Some inflammatory molecules and cells have been implicated
in the regulation of hematopoietic development in the embryo
(Espı´n-Palazo´n et al., 2014; Li et al., 2014; North et al., 2007; Ore-
lio et al., 2008). Interferon-g (IFN-g), interleukin-1b (IL-1b), tumor
necrosis factor a (TNF-a), and matrix metalloproteases (Mmps)
have been shown to enhance hematopoietic output in both
zebrafish andmouse embryos, and neutrophils are the cellular ef-
fectors in zebrafish embryos. However, the identity of inflamma-
tory cells in the mouse AGM microenvironment that may affect
hematopoietic development is unclear.Macrophages are present
in both mouse (Rae et al., 2007; Yokomizo et al., 2011) and
E34-stage human embryos (Travnickova et al., 2015) along the
A B Figure 1. CyTOF Analysis of CD45+ AGM,
Yolk Sac, and Adult Spleen Cells
(A) tSNE clusters indicated by color (12 with >10
cells) of CD45+ E10 AGM (top), E10 YS (middle)
(n = 31, 31–37 sp) and adult spleen (bottom) cells
based on 21 cell-surface markers.
(B) Heatmaps of surface-marker expression in
CD45+ AGM (top), YS (middle), and spleen (bottom)
cells with percentages of cells in each tSNE cluster
and lineage phenotype: N, neutrophils; M, macro-
phage and macrophage progenitor; L, lymphocytes
and lymphoid progenitors, P, multipotential pro-
genitor.
aortawhereHSCs emerge. Here,we exam-
ined the innate immune-cell composition of
the mouse AGM HSC-generative microen-
vironment and show that macrophages
were the most abundant hematopoietic
cell type. We identified a CD206+ pro-in-
flammatory macrophage subset that was
highly dynamic and showed that macro-
phages were a crucial cellular component
of the HSC inductive niche.
RESULTS
Macrophages Are the Most
Abundant Hematopoietic Cells in
the AGM
To investigate the cellular composition of
the AGMmicroenvironment, we performed
mass cytometry (CyTOF) on mouse E10.5
AGM cells. Cells were stained with metal-
conjugated antibodies recognizing CD45
(pan-hematopoietic cell marker), hemato-
poietic lineage markers, and endothe-
lial markers (Table S1; Key Resources
Table). Adult mouse spleen served as con-
trol. Concatenated t-distributed stochastic
neighbor embedding (tSNE) plots of AGM
and spleen cells (Figure S1A) revealed different cluster distribu-
tions and frequencies. The AGM contained a few large unique
CD45 cell clusters (10, 14, and 18), whereas most spleen cells
were CD45+ (Figure S1B). Flow cytometry analysis verified that
only 0.47%± 0.1% of AGM cells were CD45+ (Figure S2). Hence,
CyTOF analysis on unsorted AGM cells was not informative for
hematopoietic cell composition.
To more-specifically characterize the AGM hematopoietic
composition, CyTOF was performed on CD45+ cells sorted
from E10 AGM and YS tissues and an adult spleen. Concate-
nated tSNE plots (Figure 1A) revealed two major clusters of
CD45+ AGM cells in common with YS cells. Together, these
two clusters represent 83.4% and 81.7% of the AGM and YS
CD45+ cells, respectively (Figure 1B). Two other smaller clusters
of CD45+ cells (14.2% in AGMand 15.2% in YS) were in common
between these tissues. In contrast, spleen contained five major
CD45+ clusters (86.1% of cells) that were different from the clus-
ters in the embryonic tissues
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As shown in the heatmaps (Figure 1B), the major AGM and YS
tSNE clusters corresponded to phenotypic macrophages or
macrophage progenitors (M) expressing varying degrees of
cluster of differentiation 11b (CD11b); F4/80; CD206; Ly6C;
CD16/32; CD64; Mer proto-oncogenetyrosine kinase (MerTK);
and Fc fragment of IgE receptor 1a (FcεR1a). The two smaller
AGM and YS clusters appeared to be multilineage progenitors
(P), as they expressed a combination of additional markers that
included CD41, CD11c, B220, CD3, and CD43. Macrophages
and macrophage progenitors were only 0.7% of the spleen
CD45+ population. Instead, both B and T lymphoid cells and
lymphoid progenitors (L) made up four of the major populations,
as defined by Ly6C, CD41, B220, CD3, and/or CD19 expression.
The fifthmajor spleenCD45+populationwas composedof neutro-
phils (N), as defined by Ly6G expression. The AGMcontained rare
immature neutrophils (N). The AGMand YS contained no or unde-
tectable mature lymphoid or other innate immune cells but had
A B D
E
C
Figure 2. Appearance and Localization of
AGM Myeloid Cells
(A and B) Flow cytometric analysis of E8.5 to E11.5
MacGreen (A) AGM and (B) YS cells. Percentage of
GFP+ cells (top), CD45+ cells in GFP+ fraction
(middle), and CD11b+F4/80+ cells in CD45+ fraction
(bottom). Mean + SEM (n = 3/time, 2–4 AGM, 2–3
YS). ND, not done. One-way Anova with Bonferroni
correction.
(C) Maximum projection confocal image of whole-
mount E10MacGreen embryo showing the trunk. A,
aorta; V, vitelline artery. CD31+ endothelium, gray;
macrophages, green; c-Kit+ IAHCs, magenta. Scale
bar, 200 mm. High-magnification images of IAHC
(right). Scale bars, 20 mm.
(D) Immunofluorescence of E10.5 MacGreen em-
bryo transverse cryosection (10 mm) through aorta.
AGM, aorta-gonad-mesonephros; NT, neural tube;
S, somites. Yellow line, spatial boundaries of AGM.
CD34+ endothelium is in magenta, macrophages in
green, and nuclei in blue (DAPI). Scale bar, 100 mm.
(E) Total number of macrophages per mm2 in non-
hematopoietic tissues of trunk (non-AGM) and AGM
region. n = 40 (10 random sections, 4 embryos). The
data are represented as mean + SEM. One-way
Anova with Dunnett post-hoc test. *p < 0.05, **p <
0.01, ***p < 0.001. See Figures S3 and S4.
progenitor cells (overlapping with rare
tSNE spleen clusters) that appeared to be
lineage primed. E10 AGM and YS myeloid
cells were separated into two major pheno-
typic macrophage clusters by CD206
expression: CD11b+F4/80loCD206 cells
were more frequent than CD11b+F4/
80+CD206+ cells. These macrophages
and/or macrophage progenitors were the
most abundant hematopoietic cell types in
the embryonic tissues.
Macrophages Accumulate in the
AGM Prior to HSC Production
The MacGreen (Csf1rGFP) transgenic
mouse model facilitated vital imaging,
localization, and isolation of AGMmacrophages. Flow cytometry
(CD45, CD11b, F4/80, Ly6C, Ly6G, CD3, B220, and MerTK; Fig-
ure S3A) revealed that all E10.5 AGMGFP+ cells were CD45+ and
>95% of themwere positive for CD11b, F4/80, andMerTK, com-
mon macrophage markers in the adult mouse. >99% of GFP+
cells were negative for CD3 (T lymphocyte), B220 (B lympho-
cyte), and Ly6G (granulocyte) markers. Morphological examina-
tion (nucleus shape, cytoplasm) of Rapid Romanowsky stained
cells confirmed that themajority of AGMGFP+ cells weremacro-
phages (Figure S3B). Out of 500 cells screened, 74% (371) were
fully differentiated macrophages, 23% (115) were progenitors,
and only 3% (15) were immature neutrophilic band cells (Fig-
ure S3C). Thus, the MacGreen reporter defines mainly macro-
phages in the embryo.
Macrophage appearance in MacGreen AGMs (E8.5 to E11.5)
was assessed by flow cytometry (Figures 2A and S4A). No
GFP+ cells were found in the E8.5 AGM and very few were
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detected at E9. The first AGM GFP+ cells appeared at E9.5, and
at E10 the percentage increased 5-fold (p < 0.001) just prior to
the appearance of HSCs. GFP+ cells continued to significantly
increase from E10.5 (Figure 2A) and, thereafter, may have
included some HSC (monocyte)-derived macrophages. Already
at E9, most GFP+ cells were CD45+, but only 20% expressed the
mature macrophage markers CD11b and F4/80. However, at
E10, 80% of GFP+ cells were positive for CD11b and F4/80
(Figure 2A). These results suggest that GFP+ cells enter the
AGM as progenitors and later become fully mature macro-
phages. This was supported by time-course analysis of the YS
showing that 30% of GFP+ cells present at E8.5 were CD45+,
but none expressed CD11b or F4/80 (Figures 2B and S4B).
These were the predominant GFP+ population in the YS until
E9.5. Thereafter, the percentage of CD11b- and F4/80-express-
ing cells in the YS GFP+CD45+ fraction increased to 60%–95%.
Together, these data suggest that AGM macrophages are
derived from YS progenitors that enter and fully differentiate in
the AGM.
GFP+ macrophages were found in a punctate distribution
withinMacGreenE10.5 immunostained trunk regions (Figure 2C),
consistent with CD45+ and F4/80+ cell distribution shown previ-
ously (Rae et al., 2007; Yokomizo et al., 2011). Macrophages
were present throughout the trunk and AGM, and single GFP+
macrophages were in close contact with aortic endothelial cells
and intra-aortic hematopoietic cluster cells (IAHCs; CD31+c-
Kit+) (Figure 2C, enlargements).
To quantitatively examine macrophage localization within the
trunk region, E10.5 MacGreen transversal sections (10 mm)
were immunostained for CD34 (Figure 2D). The number of
GFP+ cells/mm2 was assessed in the AGM (with notochord,
gut, and mesonephros as the dorsal, ventral, and lateral bound-
aries, respectively) and non-AGM trunk region. Significantly
more macrophages were found in the AGM (near the IAHCs
and aorta) than in the rest of the trunk region (Figure 2E; p <
0.001), consistent with findings in Zebrafish embryos (Travnick-
ova et al., 2015).
Cx3cr1 Is Involved in Macrophage Progenitor
Recruitment to the AGM
Chemokine receptors and chemokines are pivotal in mediating
leukocyte recruitment to adult tissues (Garcı´a-Ramallo et al.,
2002; Mantovani et al., 2004). To identify what stimuli may attract
macrophage progenitors to the AGM, we assessed the expres-
sion of chemokine receptors that are commonly found on adult
macrophages (Ccr2, Ccr3, Ccr5, Ccr7, Cxcr2, Cxcr4, and
Cx3cr1). Flow cytometric analysis of E10 and 10.5 MacGreen
AGM (Figures 3A and S5A) and YS (Figures 3B and S5B) macro-
phages (GFP+ cells) showed the highest expression of Cx3cr1.
The other receptors were low or undetectable at E10. At E10.5,
Ccr2 and Cxcr4 expression showed some increase on AGM
and YS macrophages, and Ccr3 expression increased on YS
macrophages.
Ligand expression was tested by semi-quantitative RT-PCR
(Ccl2, Ccl11, Ccl3, Cxcl12, and Cx3cl1) on MacGreen AGM
CD31+GFP cells (endothelial and IAHC) and GFP+ macro-
phages (Figure 3C). Although Ccl2, Ccl3, and Ccl11 tran-
scripts were more abundant in AGM macrophages, Cxcl12
and Cx3cl1 were more highly expressed by CD31+ AGM cells,
suggesting that the elicitation of these chemokines by non-
macrophage cell subsets acts to attract macrophages. To
examine what CD31+ AGM cells expressed Cxcl12 and
Cx3cl1, CD31+ cells from Ly6AGFP AGMs (de Bruijn et al.,
2002) were sorted according to GFP and c-Kit expression.
This mouse transgenic reporter model allows high enrichment
of endothelial (CD31+GFPc-Kit), hematopoietic (CD31+-
GFPc-kit+), hematopoietic stem and/or progenitor (HS/PC)
(CD31+GFP+c-Kit+), and hemogenic endothelial cells (CD31+
GFP+c-Kit) (Solaimani Kartalaei et al., 2015). Compared to
endothelial cells, Cxcl12 was 1.75-fold higher in hemogenic
endothelial cells. Hematopoietic subpopulations (Figure 3D)
showed lower expression. Cx3cl1 expression was 2.5- to
3.2-fold higher in HS/PCs and hemogenic endothelial cells
(Figure 3E) compared to the other cell fractions, suggesting
a major involvement of Cx3cr1 in macrophage recruitment to
nascent and emerging IAHCs.
To test this, we isolated AGM and YS cells from Cx3cr1gfp/gfp
mice in which the insertion of the GFP gene results in a Cx3cr1
null deletion (Jung et al., 2000). Flow cytometry analysis showed
that the percentage of macrophages (CD45+c-KitCD11b+F4/
80+) in Cx3cr1gfp/gfp AGMs was significantly lower than wild
type and Cx3cr1gfp/+ AGMs (Figure 3F, left). In contrast, the per-
centage ofmacrophages in theCx3cr1gfp/gfp YSwas significantly
higher compared to those in wild-type YS (Figure 3F, right). The
inverse correlation of macrophage percentages in the AGM
versus YS suggested that the macrophage accumulation in the
YS was due to a lack of Cx3cr1-related macrophage recruitment
to the AGM.
The colony-forming unit (CFU)-C assay was performed on
AGM cells from wild-type, Cx3cr1gfp/+, and Cx3cr1gfp/gfp em-
bryos to examine whether the percentage of macrophages in
the AGM affected hematopoietic progenitor cell (HPC) numbers.
A significant reduction in colony numbers (total, CFU-GEMM,
and CFU-M) was found in Cx3cr1gfp/gfp AGMs compared to
wild type, and there appeared to be a dosage effect on
Cx3cr1gfp/+ AGM colony output (Figure 3G). Thus, Cx3cr1-medi-
ated macrophage recruitment to the AGM has a positive influ-
ence on AGM HPC output.
AGM-Associated Macrophages Dynamically Interact
with Nascent and Emerging IAHCs
Since macrophages are motile cells, vital time-lapse microscopy
(Boisset et al., 2010) was performed on thick embryo sections to
examine macrophage dynamics within E10.5 MacGreen AGMs
(Figure 4A). GFP+ macrophages were found to be adjacent to
and/or in direct contact with 28 out of 83 IAHCs (34%) examined
(20 thick sections, n = 4). Within 75-min segment, macrophages
were found to intravasate (through the aortic wall) to reach c-Kit+
cells within the lumen (Figure 4B; Video S1). Macrophages were
observed to interact for%3 h and push c-Kit+ cells towards the
aortic lumen (Figure 4C; Video S2). Moreover, some macro-
phages underwent cell division after ‘‘sensing’’ a portion of the
aorta and, thereafter, each daughter macrophage moved and in-
teracted with two separate CD31+c-Kit+ hematopoietic cells
(Figure 4D; Video S3). These data show that highly motile AGM
macrophages transiently interact with nascent and emerging
IAHCs and suggest that such interactions directly influence
HS/PC generation and/or maturation.
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Hematopoietic Progenitor Cell Numbers Are
Proportional to AGM Macrophage Percentages
The effect(s) of macrophages on AGM HPC output and function
was examined using twomacrophage depletion approaches (Fig-
ure 5A). In the first approach, BLZ945, an inhibitor of the colony
stimulating factor 1 receptor (CSF1R) was added to E10.5 Mac-
Green AGM explant cultures. The overall viability of AGM explant
cells after 72 h was unaffected by a range of BLZ945 concentra-
tions (Figure 5B). However, a significant (55%–60%) decrease in
macrophage percentages was observed in 6.7 mM and 67 mM
BLZ945-treated AGM explants (Figure 5C), as compared to
dimethyl sulfoxide (DMSO) control or 0.67 mM BLZ945-treated
AGM explants. To test if macrophage depletion affected AGM
HPC numbers, the CFU-C assay was performed. The total num-
ber of CFU-C and CFU-GEMM (granulocyte, erythrocyte, mono-
cyte, megakaryocyte) per AGM was significantly decreased in
6.7-mMand 67-mM-treated explants compared to DMSO controls
(Figure 5D), thus showing that AGM CFU-C numbers are directly
related to the percentage of AGM macrophages.
In the second approach, apoptosis-inducing clodronate-lipo-
somes (Pyonteck et al., 2013; Van Rooijen and Sanders, 1996)
were used to achievemacrophage-specific depletion (Figure 5A).
A B
C D E
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Figure 3. Macrophage Recruitment to the AGM is Cx3cr1 Mediated
(A and B) Cytofluorimetric analysis of chemokine receptors on (A) AGM and (B) YS macrophages of E10 and E10.5 MacGreen embryos. GeoMean over FMO
(fluorescence minus one). Bars represent mean + SEM (n = 3, 2–3 AGM or YS/experiment).
(C) Semi-quantitative RT-PCR analysis of Ccl2, Ccl11, Ccl3, Cxcl12, and Cx3cl1 in CD31+ cells of E10.5 MacGreen AGM. Data are fold-change over the
expression in GFP+ cells, set as one (horizontal line). Bars represent mean + SEM (n = 3).
(D and E) Semi-quantitative RT-PCR analysis of (D) Cxcl12 and (E) Cx3cl1 in E10.5 Ly6A-GFP embryos. Data normalized to CD31+ cells. Bars represent mean +
SEM (n = 3).
(F) Cytofluorimetric percentages of macrophages (CD45+c-KitCD11b+F4/80+) in AGM (left) and YS (right) of E10.5 Cx3cr1+/+ wild type, Cx3cr1gfp/+, and
Cx3cr1gfp/gfp embryos. Each symbol is an individual embryo. Error bars represent mean + SEM.
(G) CFU-C assay showing the number of colonies/AGM in E10.5 Cx3cr1+/+, Cx3cr1gfp/+, and Cx3cr1gfp/gfp embryos. BFU-E, burst forming unit-erythroid; CFU-G,
CFU-granulocyte; CFU-M, CFU-macrophage; CFU-GM, CFU-granulocyte, macrophage; CFU-GEMM, CFU-granulocyte, erythrocyte, macrophage, megakar-
yocyte. Mean + SEM (n = 4).
(C and G) Student’s t test; (D–F) one-way Anova with Bonferroni correction. *p < 0.05, **p < 0.01, ***p < 0.001. See Figure S5.
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AGM explants incubated 72 h with clodronate-liposomes
showed no change in total AGM-cell viability compared to
PBS-liposome-treated explants (Figure 5E), whereas macro-
phages (CD45+CD11b+F4/80+) were decreased significantly by
>70% (Figure 5F). Assessment of the HPC potential of the
AGMs after clodronate-liposome treatment demonstrated a sig-
nificant 43%–45% decrease in the total number of CFU-Cs, with
a significant reduction in CFU-M and multipotent CFU-GEMM
(Figure 5G) compared to control. To prove that the reduction of
HPC potential was due to the absence of macrophages and
not mediated by a direct effect of clodronate-liposomes on
committed myeloid progenitors, the lymphoid potential of AGM
HPC was assessed. AGM explants were incubated with clodro-
nate or control PBS liposomes for 72 h, and the B lymphoid
output was assessed after ten days of co-culture on OP9 cells
(Figure S6A). No change in total AGM-cell viability was found
(Figures S6B and S6C), and the percentage of macrophages
(CD45+CD11b+F4/80+) was decreased by 60% (Figures S6B
and S6D) in clodronate-liposome-treated AGMs compared to
the control. The percentages of CD45+B220+ (B cell progenitors)
and CD45+B220+CD19+ (mature B cells) populations were also
B
D
A
C
Figure 4. Macrophages Co-localize and
Interact with IAHCs
(A and B) Immunofluorescence (A) and time-lapse
imaging extracted time points (B) of transversal
sections (150 mm) of E10.5 MacGreen embryos.
Macrophages, green; CD31+ endothelium, gray;
c-Kit+ cells, blue. Scale bars, 20 mm.
(B–D) Time is indicated at the top of each image.
White arrows indicate the macrophages entering
the aorta (B) or interacting with IAHCs (A, C, D). See
Videos S1, S2, and S3.
decreased in the clodronate-liposome-
treated co-cultures (Figures S6B, S6E,
and S6F), demonstrating an effect of
macrophage depletion on B lymphoid pro-
genitors. The direct correlation between
the percentage of macrophages and the
number of HPCs, including multilineage
and lymphoid progenitors in the AGM,
supports a role for macrophages in pro-
moting HPC generation.
AGM HSC Production Is Impaired in
the Absence of Macrophages
BLZ945-inhibition and clodronate-lipo-
some treatments were performed to test
whether macrophages affect the produc-
tion of AGM HSCs. Cells from BLZ945- or
DMSO-treated AGM explants (Ly5.2 em-
bryos; 37-39 sp) were intravenously in-
jected into irradiated Ly5.1 adult mice.
When donor-cell chimerism was assessed
in the peripheral blood (PB) at 4 and
16 weeks post transplantation (Figure 5H),
only 2 of 8 mice injected with BLZ945-
treated AGM explant cells showed any
PB donor-cell chimerism. In contrast, almost all (6 out of 8) recip-
ients injected with control cells showed high percentages of
donor-derived hematopoietic repopulation.
Similarly, cells from clodronate- and PBS-liposome-treated
AGM explants (Ly5.2 embryos; 37-39 sp) were intravenously in-
jected into irradiated Ly5.1 adult mice (Figure 5I). No donor-cell
chimerism was found in the PB of 6 mice injected with clodro-
nate-treated AGM explant cells at 4 and 16 weeks post-trans-
plantation, whereas 4 out of 6 mice were reconstituted with cells
from PBS-liposome-treated AGMs. Long-term multilineage
engraftment was found in the bone marrow (BM), spleen, lymph
node (LN), thymus, and PB of recipients of PBS control AGM
cells, whereas no donor engraftment was found in recipients of
clodronate-liposome-treated AGM cells (data not shown).
Thus, macrophages play a role in the generation and/or matura-
tion of HSCs in the mouse AGM.
CD206 Discriminates AGM-Associated Macrophages
from Macrophage Progenitors
Further characterization of E10.5 AGM macrophages showed
they were negative for Flk1 (Vegfr2; Yang et al., 2004), Tie2
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(angiopoietin receptor; Fukuhara et al., 2010), and IA/IE (histo-
compatibility molecule) (Figure 6A). However, 50% of E10.5
AGM macrophages expressed CD206 (mannose receptor).
CD206+ macrophage percentages increased from E10 to E11
(Figure 6B). Cytospins of E10.5 MacGreen AGMs revealed that
CD206+ macrophages contain quantitatively more vacuoles
than CD206 cells (Figure 6C), suggesting different maturation
or activation states.
To test the states of GFP+CD206+ and GFP+CD206 cells,
chimeric co-cultures of OP9-DL1 stromal cells with cells sorted
fromMacGreen E10.5 AGMswere established and harvested af-
ter 1 week, and CD45+ cells were examined for HPC activity (Fig-
ure 6D). Both CD206 and CD206+ OP9-DL1 co-cultures yielded
equivalent numbers of CD45+ cells (not shown), and although the
CD206 cell co-cultures produced all types of CFU-C, none
were produced by the CD206+ co-cultures (Figure 6D, left
bars). Thus, CD206 cells are a mixed population of progenitors
andmacrophages, and the CD206+ cells are fully mature macro-
A
B C D
E F G
H I
Figure 5. AGM HS/PC Are Reduced upon
Macrophage Depletion
(A) Experimental set-up. CFU-C, colony forming unit in
culture; Tx, transplantation. Cytofluorimetric percent-
ages of (B and E) viable cells and (C and F) macro-
phages in AGM explants treated with BLZ945 (0.67,
6.7, or 67 mM) or clodronate-liposomes compared to
controls. Arrow, reduction in macrophage percent-
ages upon treatment. (D and G) CFU-C numbers per
AGM explant upon BLZ945 or clodronate-liposome
treatment compared to control with percentage
reduction shown. BFU-E, burst forming unit-erythroid;
CFU-G, colony forming unit-granulocyte; CFU-M,
colony forming unit-macrophage; CFU-GM, colony
forming unit-granulocyte, macrophage; CFU-GEMM,
colony forming unit-granulocyte, erythrocyte, macro-
phage, megakaryocyte. PBS-L, PBS-liposomes;
Clod-L, clodronate-liposomes. In vivo transplantation
of (H) BLZ945-treated and (I) clodronate-liposome-
treated AGM explant cells into irradiated adult Ly5.1
recipients. Chimerism (%CD45.2+) in peripheral blood
of recipients at 4 and 16 weeks post-transplant. Each
symbol = one mouse. Triangles, BLZ945 or Clod-L
treated AGMs; circles, controls (n = 3, Student’s t test).
(B, C, D, F, G)Mean + SEM (n = 4). (H, I) The horizontal
lines represent the mean. *p < 0.05, **p < 0.01, ***p <
0.001. See Figure S6.
phages (now defined as AGM-associated
macrophages, AGM-aMs).
Spatial localization of AGM-aMs and
CD206GFP+ cells in E10.5 MacGreen
AGMand non-AGM trunk regionswas quan-
titatively assessed (Figure 6E). CD206
GFP+ cells were found in equal num-
bers/mm2 in the non-AGM and AGM trunk
regions and similar numbers of AGM-aMs/
mm2 were found in the non-AGM trunk re-
gion. However, the AGM contained signifi-
cantly higher numbers of AGM-aMs/mm2
(2.5-fold more). Moreover, some were
engaged with aortic cells (Figure 6F), sug-
gesting that AGM-aMs play a role in AGM HS/PC generation
through interaction with nascent and emerging IAHCs.
AGM-Associated CD206+ Macrophages Enhance
Endothelial-to-Hematopoietic Transition
The influence of AGM-aMs and CD206GFP+ cells on the hemo-
genic activity of E10.5 AGM endothelial cells (ECs, CD31+-
CD45CD41) was tested in chimeric co-cultures on OP9-DL1
cells (Figure 6D, right bars). Cell combinations included:
ECs alone, ECs + CD206GFP+, and ECs + AGM-aMs. After
1 week, cells were harvested and 53103 CD45+ cells were as-
sayed for HPC activity. ECs alone yielded 203 ± 25 CFU-C.
ECs + CD206GFP+ cells yielded 311 ± 17 CFU-C (sum of EC-
generated CFU-C [203 ± 25] plus CD206GFP+-cell-generated
CFU-C,106 ± 11) (Figure 6D, left bar). In contrast, ECs + AGM-
aMs yielded 366 ± 13 CFU-C. As no CFU-Cs were generated
by AGM-aMs in the absence of ECs (Figure 6D, left bar), the
presence of AGM-aMs increased the CFU-C output of ECs by
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56%. Moreover, a significant increase in CFU-M and CFU-
GEMM was found in ECs + AGM-aMs compared to ECs alone
(Figure 6D), indicating an inductive cooperation between AGM-
aM and ECs in the generation of HPCs. To examine whether
direct AGM-aM and EC interactions were required, we estab-
lished transwell cultures. After 7 days, the same induced CFU-
C output of ECs + AGM-aMswas observed in non-contact trans-
well conditions as seen in contact conditions (Figure 6G), sug-
gesting that in prolonged cultures (as opposed to %3 h in vivo
contact; Figure 4), the non-contact output is likely a result of sol-
uble factor accumulation in the medium (see Discussion).
AGM-aMs Are Inflammatory and Transcriptionally
Distinct from Macrophage Progenitors
RNA-sequencing datasets of MacGreen AGM GFP+CD206+ and
GFP+CD206 populations were compared. Unsupervised prin-
cipal component analysis (PCA) (Figure 7A) showed AGM-aMs
and GFP+CD206 cells in two distinct clusters. Differentially ex-
pressed gene (DEG) analysis identified 1,265 genes (of 21,911)
significantly altered with adjusted p value (false discovery rate,
FDR) <0.05 in AGM-aMs compared to GFP+CD206 cells (Table
S2). Hierarchical clustering of the top 50 DEGs (Figure 7B) showed
two distinct expression patterns (Table S3). Among 320 genes
(log2FC1.5/1.5, FDR % 0.05), 147 were upregulated in AGM-
aMs (log2FCR 1.5, FDR% 0.05) and showed a dominant inflam-
matory signature with a specific expression of Ccl24, Ccl9, Igf1,
Tnf,Bmp2,Pf4,Cxcl3,Gas6,Ccl12,Ccl7,Ccl2, and Il18 (Figure7C).
Validation of pro-inflammatory gene expression by qRT-PCR (Fig-
ure 7D) confirmed the upregulation of Tnf,Ccl24,Ccl9, Igf1,Bmp2,
Pf4,Ccl2, andCcl7 in AGM-aMsand, thus, AGM-aMscontribute to
the pro-inflammatory microenvironment of the AGM.
In addition, the relative expression of Ifna, Ifng, and Il1b
(previously reported to affect HS/PC generation in mouse and
zebrafish embryos; Li et al., 2014) andMmp9 andMmp13 (met-
alloproteinases involved in extracellular matrix [ECM] degrada-
tion and aortic HS/PC mobilization in zebrafish embryos; Trav-
nickova et al., 2015) was tested in AGM-aMs and
GFP+CD206 cells. No upregulated expression of the cytokines
was found in AGM-aM compared to CD206 cells (Figure 7D),
and a mixed ‘‘metalloproteinase signature’’ was found in both
fractions (Figure 7E). However, Mmp9 and Mmp13 were signifi-
cantly upregulated in AGM-aMs, as revealed by qRT-PCR (Fig-
ure 7F). Together, these data reveal that AGM-associated
(CD206+) macrophages play a positive role in the generation
and/or maturation of HPCs and HSCs and may assist in ECM
degradation.
DISCUSSION
We have shown that macrophages play a positive role in HSC
generation. They are the most abundant innate immune cell
type present in the AGM microenvironment prior to HSC gener-
ation and are pro-inflammatory. Macrophage progenitors gener-
ated in early waves of hematogenesis in the YS (Bertrand et al.,
2005; Palis et al., 1999) are recruited through the Cx3cr1
signaling axis to the AGM, where they mature, express CD206,
and dynamically interact with nascent and emerging aortic he-
matopoietic cells to influence AGM HS/PC production.
Phenotypic characterization of CD45+ hematopoietic cell
types in the AGM by CyTOF analysis for 21 hematopoietic line-
age markers revealed little phenotypic heterogeneity. Of 7 clus-
ters identified in tSNE and heatmap analyses, >83%of cells were
phenotypic macrophages and macrophage progenitors.
Whether these cells represent progenitors previously described,
such as pre-macrophages (Stremmel et al., 2018) or EMPs
(Frame et al., 2013; Palis et al., 1999) is uncertain. The CyTOF
profiles of CD45+ macrophage and progenitors (clusters 5 and
6) showed a high degree of similarity between the AGM and
YS. The only detectable difference was the expression of c-Kit
by YS CD11b+F4/80CD206 cells (cluster 5), thus suggesting
that heterogeneity or plasticity in macrophages in specific em-
bryonic hematopoietic tissues is due to local microenvironment
and/or differentiation state.
>14% of AGMCD45+ cells (clusters 9 and 11) were phenotypic
multipotent HPCs. These two clusters were found in the YS at a
similar frequency and at a much lower frequency in the spleen
with some marker variation. CD41 (embryonic progenitor and
mature megakaryocytic marker) and CD43 (adult pan-leukocyte
marker except resting B cells) were expressed by these cells in
all three tissues. Cluster 9 cells co-expressing B220 and F4/80
were likely to be bi-potent macrophage B cell progenitors and
functionally defined AGM myeloid-B lymphoid progenitors previ-
ously reported (Bo¨iers et al., 2013; Godin et al., 1995; Katsura,
2002). Cluster 11 cells expressing CD11c, B220, CD3, and F4/80
were likely multipotent cells with innate immune fate for innate
lymphoidcells (ILCs) anddendritic cells.Whether these embryonic
cells are functionally similar to adult cells has yet to be established.
All major AGM and YS cell clusters (5, 6, 9, 11) highly ex-
pressed the MerTK macrophage marker, verifying that macro-
phages are the dominant AGM and YS hematopoietic cell type.
In contrast, only rare spleen clusters (2, 5, 6) expressed MerTK.
Low expression of NKp46 was also found in most of these clus-
ters. In the adult, NKp46 is a marker for natural killer (NK) cells
alongside NK1.1. However, no CD45+ cells in the AGM, YS, or
spleen were NK1.1+. Because it is known that NK1.1+ spleen
cells are at low frequency and difficult to detect, it is as yet uncer-
tain whether NK cells are present in embryonic tissues and/or
whether the NKp46 marker is expressed by other non-NK-cell
lineages. Similarly, no mature CD19+ B cells were found in the
AGM or YS. Although neutrophils and neutrophil progenitors
make up about 10% of the spleen CD45+ cell population (clus-
ters 1 and 2), no cluster 1 and rare cluster 2 cells were found in
the AGM and YS. Thus, the AGM and YS show a bias towards
macrophages and progenitor cells, and CyTOF analysis with
additional markers should aid in determining the heterogeneity
within the embryonic progenitor populations.
As detected by fate mapping (Gomez Perdiguero et al., 2015),
EMPsmigrate from the YS to the caudal half of themouse embryo
betweenE8.5 andE9.We found that these early generatedYSpro-
genitorsappear in theAGMbyE9alreadyexpressing theCD45sur-
face marker, but the CD11b and F4/80 mature macrophage
markers were expressed only after arrival in the AGM. Macro-
phages accumulated in the AGM and were found to dynamically
interact with nascent and emerging IAHCs. We confirmed that
macrophage progenitor appearance in the AGM was, at least
in part, Cx3cr1 mediated (Mass et al., 2016). However, since one-
thirdof the totalpercentageofAGMmacrophages is still detectable
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inCx3cr1/mice, we suggest that other chemokines and chemo-
kine receptors such as Cxcl12 and Cxcr4 may be involved.
Vital time-lapse imaging revealed the rapid interstitial move-
ment of macrophages in and around the E10.5 aorta. We
observed Csf1r+ macrophages entering into the aortic lumen
from the surrounding mesenchymal tissue of the AGM. This intra-
vasation was in contrast with a recent report that YSmacrophage
progenitors colonize embryonic tissues through the circulation
(extravasation) (Stremmel et al., 2018). Moreover, we showed
that macrophages dynamically interacted with aortic CD31+c-
Kit+ cluster cells. In some cases, a macrophage underwent cell
division and the daughter cells interacted with adjacent or nearby
aortic CD31+c-Kit+ cluster cells. The cell-cell interactions and
possible regulatory cross-talk occurring transiently over a few
short hours of developmental time (%3 h) suggests a role(s) for
macrophages in the process of HS/PC generation. The AGM
HSC-generative microenvironment is present between E10 and
E12, a time when the mouse embryo is undergoing rapid growth
and remodeling (Yokomizo et al., 2011). Thus, we propose that
direct contact of AGM-aMs with EC is needed in vivo, whereas
AGM-aMs can regulate HS/PC generation in non-contact condi-
tions in vitro through soluble signals to EC over many days.
The depletion of AGM macrophages with clodronate-lipo-
somes and Csf1r inhibitor BLZ945 demonstrated that macro-
phages are indeed important for the production of HSCs. Others
have reported that these treatments specifically deplete phago-
cytic cells in vivo (Pyonteck et al., 2013; Van Rooijen and
Sanders, 1996). When AGM explants were treated in vitro for
3 days, both the clodronate-liposome and the BLZ945 treatment
decreased the percentage of viable macrophages without
affecting the overall viability of other AGM cells. The BLZ945
concentration normally used in cell cultures (0.67 mM) was insuf-
ficient to eliminate macrophages, likely due to the 3D mass of
AGM explants. Depletion (60%) was achieved with increased
A B
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Figure 6. Majority of E10.5 AGM Macro-
phages are CD206+
(A) Histograms (white), representative of 4 inde-
pendent experiments, show percentages of AGM
macrophages expressing Flk1, Tie2, IA/IE, and
CD206 in E10.5 MacGreen embryos. FMO, gray.
(B) Time course of %CD206+ cells in E10–E11
MacGreen AGM. The data are represented as
mean + SEM (n = 3).
(C) Rapid Romanowsky staining of cytospun E10.5
MacGreen (CD45+CD11b+F4/80+GFP+CD206+/)
macrophages. Left, GFP+CD206; right, GFP+
CD206+ cells. Scale bar, 20 mm. Black box sepa-
rates cells from different slides. Number of vacu-
oles in CD206GFP+ cells (white bars) and
CD206+GFP+ macrophages (gray bars). 100–120
cells/population scored.
(D) Schematic of OP9-DL1 co-culture experi-
ments (top). CD206GFP+=GFP+CD45+CD206;
CD206+GFP+=GFP+CD45+CD206+; EC, endo-
thelial cells (CD45CD41CD31+). Cell combina-
tions plated on OP9-DL1 are indicated under the
graph. Number of CFUs in culture (CFU-C) per
53103 CD45+ cells. BFU-E, burst forming unit-
erythroid; CFU-G, colony forming unit-gran-
ulocyte; CFU-M, colony forming unit-macro-
phage; CFU-GM, colony forming unit-gran-
ulocyte, macrophage; CFU-GEMM, colony
forming unit-granulocyte, erythrocyte, macro-
phage, megakaryocyte.
(E) Total number of CD206GFP+ and CD206+-
GFP+ cells/mm2 in non-hematopoietic trunk region
(non-AGM) and AGM. n = 40 (10 random sections,
4 embryos), two-way ANOVA with multiple com-
parisons corrected by a Tukey’s range test, ***p <
0.001. The data are represented as mean + SEM.
(F) Fluorescent image of a representative E10.5
MacGreen transverse section (10 mm) showing an
AGM-associated macrophage (AGM-aM) along
the aortic wall (left). Scale bar, 100 mm. Boxed area
is enlarged on the right; scale bar, 20 mm. CD34,
white; CD206, red; GFP, green; and DAPI, blue.
(G) Number of CFU-C per 53103 CD45+ obtained
after co-culturing CD206+GFP+ macrophages in
contact with or separate from endothelial cells.
(D and G) mean + SEM (n = 4). Student’s t test, *p <
0.05, **p < 0.01.
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BLZ945 concentration but was still less effective than that medi-
ated by clodronate liposomes (77%). These complementary
methods revealed a direct correlation between the reduced
macrophage percentages and the decreased number of multi-
potent HPC CFU-C and lymphoid progenitors compared to
control explants. Importantly, the in vivo transplantation of
clodronate-liposome- and BLZ945-treated AGM cells showed
no or little donor-derived hematopoietic repopulation of adult
irradiated mice. Despite reports that HSCs are Csf1r expressing,
the fact that clodronate-liposome treatment eliminates macro-
phages and affects both HPC and HSC output of AGM explants
strongly supports an active role for macrophages in the AGM
HS/PC generative microenvironment.
Many groups over the years have attempted to develop macro-
phage-deficient mouse models. Pu.1-transcription-factor-defi-
cient mice have no detectable embryonic macrophages, and de-
pending on the deletion strategy, such mice die either by E18
(Scott et al., 1994) or within 48 h from birth (McKercher et al.,
A B C
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Figure 7. Transcriptomic Differences between CD206– and CD206+ AGM Cells
(A) Principal component analysis (PCA) on all expressed genes in GFP+CD206+ (green) and GFP+CD206 cells (purple) (n = 3, 4 AGMs/experiment).
(B–E) Heatmap calculated from the regularized log transformation counts of (B) the top 50 most variable genes, (C) cytokines, and (E) proteinases differentially
expressed in GFP+CD206+ (green) and GFP+CD206 (purple) AGM populations. Samples are clustered using average linkage and Pearson correlation. Samples
are vertical and genes horizontal; red = upregulated and blue = downregulated genes. Semi-quantitative RT-PCR (mean + SEM) of (D) inflammatory factors (n = 5,
3–4 AGM/experiment) and (F) Mmp9 (left) and Mmp13 (right) (n = 5) in E10.5 MacGreen GFP+CD206 and GFP+CD206+ cells. (D) Expression in CD206+ mac-
rophages normalized over CD206 cells (horizontal line).
(F) Expression in CD206+ macrophages (gray) normalized over CD206 cells (white).
(D and F) Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001. See Tables S2 and S3.
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1996). However, it is unknownwhetherPu.1/AGMcontains any
YS-derived macrophages or AGM-aMs. Similarly, it is not known
whether AGM-aMs are present in Csf1-deficient mice (op/op),
which exhibit a general impairment in normal, steady-state hema-
topoiesis (Wiktor-Jedrzejczak et al., 1982). Only a small percent-
age (1%) of mature macrophages remain in op/op mice, and
such mice appear to correct the hematopoietic defects as they
age (Begg et al., 1993). With further characterization, these and
newly developedmodelsmay be useful in establishingmore com-
plex chimeric cultures for studies of AGM HSC generation.
At least two types of myeloid populations exist in the AGM:
macrophages expressing CD206 (mannose receptor) and
CD206 cells, which are a mixed population of macrophages
and progenitors. CD206+ macrophages contain more vacuoles
than the CD206 cells and are more frequent in the AGM region
compared to the rest of the embryo. The CD206mannose recep-
tor is a C-type lectin that functions in endocytosis and phagocy-
tosis, playing an important role in immune homeostasis (Taylor
etal., 2005). It is amarkerof terminallydifferentiatedmacrophages
in human (Mokoena and Gordon, 1985) and mouse embryonic
macrophages by E10 (Takahashi et al., 1998). Mice deleted for
the mannose receptor show major problems in the clearance of
mannose-expressing proteins (Lee et al., 2002). The lack of fetal
lethality in germline-deleted mice suggests that it does not affect
the embryonic generation of the adult hematopoietic system and
therefore serves only as a marker of AGM-aMs.
CD206 expression is generally accepted as an indicator of anti-
inflammatory or ‘‘M2’’ macrophages in the adult mouse (Martinez
et al., 2009; R}oszer, 2015). We found that AGM CD206+ macro-
phages expressed a pro-inflammatory signature. Of the pro-
inflammatory molecules expressed by AGM-aMs, TNF-a is a
modulator of HS/PC formation in zebrafish and mouse embryos
(Espı´n-Palazo´n et al., 2014); Ccl24 (Ccr3 ligand) is upregulated
in adultmacrophages in TNF-a-rich environments and recruits eo-
sinophils during asthma and allergic reactions (Lampinen et al.,
2004); Ccl9 (macrophage inflammatory protein 1-g or Ccr1 ligand)
correlates with leukocyte recruitment in adult mice (Nu´n˜ez et al.,
2010); Igf1 (insulin-like growth factor 1) participates in immune-
metabolic cross-talk in stress conditions (Spadaro et al., 2017)
and promotes embryo and adult erythropoiesis (Kadri et al.,
2015; Yumine et al., 2017); Bmp2 (bone morphogenic protein 2)
is secreted by pro- and anti-inflammatory macrophages (Dube
et al., 2017) and modulates human HSC proliferation in vitro (Bha-
tia et al., 1999); platelet factor 4 (Pf4, Cxcl4) attracts monocytes
and neutrophils in inflammatory responses, supports hematopoi-
etic cell survival, promotes macrophage maturation, and is ex-
pressed by HSCs in the mouse embryo (Calaminus et al., 2012);
and Ccl2 and Ccl7 recruit leukocytes during inflammatory re-
sponses (Bardina et al., 2015). AGM-aMs did not express more
IFN-g and IL-1b (Espı´n-Palazo´n et al., 2014; Kim et al., 2016; Li
et al., 2014; Orelio et al., 2008; Z.L., unpublished data) than
CD206-cells suggesting that these cytokines may be produced
byeither cell subset. It will be noteworthy to examinewhat specific
roles these pro-inflammatory molecules play in vivo in the AGM,
alone and in combination with each other and factors produced
by other microenvironmental cells.
It is important to note that our results on pro-inflammatory
AGM-aMs are in contrast with those in zebrafish embryos, where
proinflammatory cytokines are produced mainly by neutrophils
(Espı´n-Palazo´n et al., 2014). Rare immature neutrophilic band
cells were found in our cytospins and are likely to be the minor
Ly6G+ population seen by CyTOF. These immature cells are not
phagocytic. Thus, they would not be eliminated during clodro-
nate-liposome treatment that hence should have resulted in an in-
crease in HSC and HPC numbers, not a decrease. We cannot
completely rule out the influence of immature neutrophil band
cells on HPCs because, after clodronate-liposome treatment,
someHPCs (but no HSCs) were still present in the cultures. In Ze-
brafish embryos, macrophages have been found to dynamically
interact with aortic hematopoietic cells and produce Mmp9 and
Mmp13, which degrade the ECM to mobilize the emerging cells
(Travnickova et al., 2015). We too have found expression of these
Mmps inmouse AGM-aMs and suggest that these pro-inflamma-
tory macrophages play an additional role to mobilize the aortic
hematopoietic clusters of the mouse embryo.
Taken together, our data in the mouse embryo show that
AGM-associated macrophages expressing the mannose recep-
tor and pro-inflammatory molecules dynamically interact with
nascent and emerging aortic cluster cells to affect HPC and
HSC production in the AGM. These AGM-associated macro-
phages elaborate signals that likely affect processes such as
HS/PC fate decisions, HS/PC function, ECM degradation, and/
or mobilization of newly generated HS/PC. Our results provide
a starting point for approaches with these macrophages to
recreate the dynamic in vivo developmental microenvironment
for the de novo production of robust HSCs.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Elaine
Dzierzak (elaine.dzierzak@ed.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All mice were housed and bred in animal facilities at the University of Edinburgh, in compliance with the Home Office regulations. All
procedures with animals were conducted by a Home Office UK Project License (PPL 70/8076) and approved by the University of
Edinburgh Ethical Review Committee.
METHOD DETAILS
Mouse and embryo generation
Wild type C57BL/6 from animal facility of the University of Edinburgh,MacGreen (B6.Cg-Tg(Csf1r-EGFP)1Hume/J) (Sasmono et al.,
2003),Cx3cr1-GFP (B6.129P2(Cg)-Cx3cr1tm1Litt/J )(Jung et al., 2000) and Ly6aGFP (B6.Cg-Tg(Ly6a-EGFP)G5Dzk/J) (de Bruijn et al.,
2002) mice were used for timed mating. Embryos were generated from MacGreen (mixed background backcrossed six times into
C57BL/6HsdJOla) and Ly6aGFP (C57BL/6HsdJOla background) males (two to eight months old) crossed with wild type female
mice (two to six months old) and Cx3cr1gfp/wt males (two to eight months old, mixed background backcrossed five times into
C57BL/6HsdJOla) crossed with Cx3cr1gfp/wt females (two to six months old). Accurate embryo staging was done by somite pair
counts. Ly5.1 mice (B6.SJL-PtprcaPepcb/BoyCrl, two to four months old) were used as recipients of transplantation experiments.
Mass cytometry (CyTOF)
Mass cytometry antibodies were either labeled in-house by using antibody-labeling kits (Fluidigm, California, USA) or purchased (Flu-
idigm). Antibodies were individually titrated and optimized prior to use. Six palladiummetal isotopes were used for live cell barcoding
of samples with CD45 (Mei et al., 2015), while keeping CD45-89Y as a common channel to clearly identify cells expressing varying
degrees of CD45. Briefly, individual samples fromYS, AGMand adult C57BL/6mouse spleenswere incubatedwith respective CD45-
Pd + antibodies in PBS for 30min at room temperature, washed twicewith FACS buffer (PBS supplementedwith 0.5%BSA), and then
pooled into one sample. This was followed by incubation of samples with the cocktail of primary panel antibodies (SuppTable1 and
KRT) for 20 min at room temperature and washing with FACS buffer. After washing, samples were incubated with intercalating
solution (Iridium in MaxPar Fix/Perm buffer (both Fluidigm)) overnight at 4o C. Prior to acquisition, the samples were washed twice
with MilliQ water. Barcoded composite samples were acquired on a Helios mass cytometer (Fluidigm). Quality control and tuning
processes on the Helios were performed on a daily basis before acquisition. Data from different days and across acquisition time
was normalized by adding five-element beads to the sample immediately before acquisition and using the MATLAB-based normal-
ization software (Version 2013b) (Finck et al., 2013).
Mass cytometry statistical analysis
Live cells were exported by manual gating on Event_length, DNA (191Ir and 193Ir), CD45-89Y, and live cells (198Pt) using FlowJo
software (Version10.1r5, Tree Star) (Krieg et al., 2018). For further analysis, we used our customized R workflow (Nowicka et al.,
2017). All analyses on CyTOF data were performed after arcsinh (with base equal to 5) transformation of marker expression. In brief,
pre-processing of the raw data was followed by dimensionality reduction and visualization by t-Distributed Stochastic Neighbor
Embedding (t-SNE) with parameters as listed in the figure legends, clustering with FlowSOM into initial 100 nodes (Van Gassen
et al., 2015), followed by expert-guided manual metaclustering.
Whole-mount Images
MacGreen embryos were fixed in 2% PFA-PBS for 20min and dehydrated in 50% methanol in PBS for 10 min followed by 100%
methanol for 2x10min. The body wall was trimmed on both sides of the embryo, exposing the AGM for immunochemistry. Embryos
were then rehydrated in 50%methanol in PBS (Sigma-Aldrich, Missouri, USA) for 10min following by PBS and incubated overnight at
4C with rabbit anti-GFP (1:1000; MBL International, Massachussetts, USA) and rat anti-c-Kit (1:500; eBioscience, Thermo Fisher
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Scientific, Massachussetts, USA). At 4C, embryos were washed in PBS-MT (PBS supplemented with 1% skim milk (BioRad,
California, USA) and 0.4% TritonX-100 (Acros Organics, Thermo Fisher Scientific) for 3x2hr and incubated overnight with anti-rabbit
AlexaFluor488 (1:1000; Invitrogen) and anti-rat AlexaFluor647 (1:5000; Invitrogen, Thermo Fisher Scientific), then washed in PBS-MT
for 3x2hr and incubated overnight with biotinylated rat anti-CD31 (1:500; BD Biosciences, New Jersey, USA), then washed in PBS-
MT for 3x2hr and incubated overnight with Streptavidin AlexaFluor555 (1:500; Invitrogen, Thermo Fisher Scientific). Embryos were
then washed in PBS supplemented with 0.4% TritonX-100 (PBST) and mounted in a FastWell (Sigma-Aldrich) for imaging using a
Leica SP5 confocal microscope. Using Fiji (ImageJ), a maximum projection image with merged colour channels was generated.
Tissue Sections
MacGreen embryos were fixed in 2%PFA-PBS for 30mins and washed in PBS for 10mins at 4C. Embryos were then equilibrated in
20%sucrose in PBS for 30mins at 4C. Embryoswerewashed in OCT embeddingmatrix for frozen sections (CellPath, Thermo Fisher
Scientific), using tissue paper to remove remaining sucrose. Each embryo was placed in an individual mould containing OCT and
orientated forelimbs exactly above hindlimbs and YS to one side before being quickly frozen on dry ice in absolute ethanol. Frozen
OCT blocks were then removed from the mould, wrapped in ParafilmR and stored at -80C. 10mm sections were taken along the
length of the AGM of MacGreen embryos using a Bright OTF5000 cryostat and placed on poly-lysinated glass slides (Thermo Fisher
Scientific) 8 sections/slide that were then stored at -20C. For immunohistochemistry, slides were blocked in 50% Avidin D solution
(Vector Laboratories Inc., California, USA) diluted in PBS supplemented with 0.05% Tween20 and 1% bovine serum albumin (BSA)
(PBSblock) and washed in PBST. Slides were incubated for 1hr with rat anti-CD34 (1:200; eBioscience, Thermo Fisher Scientific), rab-
bit anti-GFP (1:1000; MBL International) and rat anti-CD206 (MR; 1:50; BioLegend, California, USA) diluted in PBSblock at RT and
washed in PBST, then incubated for 1hr with anti-rabbit AlexaFluor488 (1:1000; Invitrogen, Thermo Fisher Scientific) and Streptavidin
Cy3 (1:2500; Jackson ImmunoResearch Laboratories, Pennsylvania, USA)) diluted in PBSblock at RT and washed in PBST before
10mins incubation in DAPI (1:1000) diluted in PBSblock at RT. Slides were washed and mounted with coverslips using SlowFade
Diamond Anti-Fade Mountant (Invitrogen, Thermo Fisher Scientific). Sections were imaged on a Leica SP5 confocal microscope.
10 sections from along the length of the AGM were imaged per embryo. Using Fiji (ImageJ), a maximum projection image of each
section with merged colour channels was obtained.
Time-lapse ex vivo imaging
MacGreen embryos were stained by intra-aortic flushing with anti-CD31-AF647 (clone MEC13.3, Biolegend) and anti-c-Kit-BV421
(clone 2B8, BD Biosciences) antibodies and incubated 30min at 4C in PBS + 10% FBS. The embryos were then transversally
thick-sectioned with an automatic tissue chopper into 150mm sections that were embedded in low melting agarose (Sigma-Aldrich)
and placed in a chamber ring support (Attofluor cell chamber, Invitrogen, Thermo Fisher Scientific) closed at the bottom with a round
glass cover slip (Menzel Gl€aser, VWR, Pennsylvania, USA). The agarose-embedded sections were then covered with MyeloCult
M5300 medium (StemCell Technologies) supplemented with hydrocortisone succinate 106M (Sigma-Aldrich) and mIL3 20ng/ml
(Peprotech, New Jersey, USA). Overnight imaging was performed either on a CSU-W1 Spinning disk confocal (Videos S1 and S2)
or a Andor spinning disk (20x objective) and analyzed with the integrated software with a 10-minute interval for a total of 14–16 h,
step size 3 mm and a z-range of 20–40 steps. The samples were maintained at 37C. Videos were analyzed with Slidebook software
(3i, Colorado, USA). Lateral drifting of the section imaged in the movie 2 was corrected with Huygens software.
AGM explant cultures
AGM fromE10.5MacGreen embryos (34-39sp) were dissected and cultured for 72 h at 37 Cwith 5%CO2 at the air-liquid interface in
a six well plate on ametal mesh coveredwith duraporemembrane filter paper (Millipore,Massachusetts, USA). TheMyeloCult M5300
medium (StemCell Technologies) used was supplemented with hydrocortisone succinate 106M (Sigma-Aldrich).
CFU-C assay and stem cell transplantation
Cells from AGM or AGM explants were digested at 37C in 0.125% type 1 collagenase (C0130, Sigma- Aldrich) for 45 min and then
cultured inMethylcellulose (M3434; StemCell Technologies, Canada) at 37 Cwith 5%CO2. Colonies were counted and scored after
10 days.
AGM explant cells were prepared into single cell suspensions, as described above, and injected intravenously into irradiated Ly5.1
recipients two doses of 4.5 Gy of g-irradiation). After 4 and 16 weeks, peripheral blood was taken for CD45.1- and CD45.2- flow
cytometric analysis. Recipient mice are considered reconstituted whenR5% of cells are donor-derived.
OP9/OP9-DL1 co-culture system
AGM derived endothelial cells (CD31+CD45CD41) and macrophages (CD206+ and CD206) were co-cultured with OP9-DL1 cells
at 37 C with 5% CO2 in cytokine containing aMEM (SCF100ng/ml, IL3 100ng/ml and Flt3-ligand 100ng/ml, Peprotech). After seven
days of co-culture, CD45+ cells were FACS sorted and plated in methylcellulose (M3434; Stem Cell Technologies). Colonies were
counted and scored after 10 days. For the transwell experiment, Corning HST Transwell (Thermo Fisher Scientific) with 3mM pores
were used to separate the endothelial cells (bottom of the well) from macrophages. CD206+ macrophages were put either in contact
with endothelial cells or at the top of the transwell filter. After 7 days of co-culture, at 37 Cwith 5%CO2, CD45
+ cells derived from the
endothelial cells (bottom of the transwell) were FACS sorted and plated in methylcellulose. Colonies were counted and scored after
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10 days. For the lymphoid potential progenitor assay, AGM explants were digested and single cells plated on OP9 stromal cells in
aMEMwith the addition of IL7 20ng/ml and Flt3 20ng/ml. Medium was replaced every 3 days and the cells were plated on fresh OP9
every 7 days. Flow cytometric analysis for macrophage and B cell markers was performed after 10 days of co-culture.
BLZ945 and Clodronate-liposome treatment
AGM explants were pre-incubated for 2 h at 37C in MyeloCult M5300 medium + BLZ945 (0.67, 6.7 or 67 mM) or clodronate-lipo-
somes (1:5 dilution) and their controls, DMSO and PBS-liposomes, respectively. Then the explants were recovered from the wells
with curved forceps and placed for 72 h on the metal mesh + filter paper (see above for details). The treatments were added to
the explant medium at time zero and 48 h later.
Flow analysis and sorting
Cells from AGM, YS, culture systems and hematopoietic organs of adult mice were blocked in PBS+10%FBS and then stained with
antibodies (SupTable4) for 30 min on ice. Excess of antibodies was washed away with PBS/FBS before flow cytometry analysis.
Sorted cells were collected in 50% PBS/FBS for functional analyses or in Qiagen RLT lysis buffer for RNA extraction. Cytometry
was performed on LSR Fortessa, Aria॥ and Fusion (BD Bioscience).
Gene Expression Analysis
RNA from sorted cells was extracted by using RNeasyMicro Kit (Qiagen, Germany). cDNAs were generated using oligdT primers and
SuperScript III Reverse Transcriptase (Invitrogen Thermo Fisher Scientific) according to manufacturer instructions. RT-PCR were
performed by using Fast SYBRGreenMasterMix (Thermo Fisher Scientific) on an ABI 7900machine (Applied Biosystems, California,
USA). See Table S5 for the list of the primers used.
RNA-seq
RNA from sorted cells (MacGreen GFP+CD206 and GFP+CD206) was extracted by using RNeasy Micro Kit (Qiagen) and the
RNASeq samples were prepped according to the Smart-seq2 method (Picelli et al., 2013). The samples were then sequenced
according to the Illumina TruSeq Rapid v2 protocol on the HiSeq2500 machine with a single read 51 bp and dual 9+9bp index
and mapped against the requested reference using HiSat2 (version 2.0.4). Gene expression values were called using htseq-count
(version 0.6.1).
Sequencing alignment and Quantification
Fastq files of 51bp single-end reads were quality controlled using FASTQC. Reads were then aligned to the GENCODE M14 mouse
reference genome (mm10) using STAR aligner (version 2.3) for Linux Ubuntu, with default options, and ran over 8 threads per sample.
For improved accuracy, the exon junction coordinates from the reference annotation were used. Resulting BAM files from different
lanes were merged into one sample. Gene quantification on the merged samples was performed using featureCounts from the sub-
Read package.
Statistical analysis for differentially expressed genes
All statistical calculations have been performed in R programming language (version 3.2.3). Geneswith expression 0 or 1 were filtered
out. Differential expression analysis was performed using DESeq2 package to identify significantly differentially expressed genes
with controlled False Positive Rate (B&H method) at 5% (FDR% 0.05). Up-regulated genes were selected at a minimum log2 fold
change of 1.5 and down-regulated genes at a minimum log2 fold change of 1.5. Principle component analysis was performed
on the regularized log transformed (rlog) expression matrix on all genes. Heatmaps were drawn on the regularized transformed
(rlog) expression matrix (pheatmap package). Pearson correlation and average linkage were used for hierarchical clustering.
QUANTIFICATION AND STATISTICAL ANALYSIS
All graphs were generated using GraphPad Prism 5. A one-way Anova with Dunnett post-hoc test was used to compare total macro-
phages numbers in the AGM to that in the non-AGM region. To compare tissue section cell counts for GFP+CD206 and GFP+CD206+
macrophages across the different regions, a two-way ANOVAwith multiple comparisons corrected by a Tukey’s range test was used.
A one-way ANOVA corrected by Bonferroni’s test was used to compare more than 2 groups, whereas the Student’s t test was used
when the groups to compare were only two. Details of the statistical test used can be found in the figure legends. Significance was
defined as p < 0.05. *p < 0.05, **p < 0.01, ***p < 0.001.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GSE130579.
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